Lasa Total Stockholder Equity vs Total Current Liabilities Analysis

LASA Stock   27.18  0.76  2.72%   
Lasa Supergenerics financial indicator trend analysis is infinitely more than just investigating Lasa Supergenerics recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Lasa Supergenerics is a good investment. Please check the relationship between Lasa Supergenerics Total Stockholder Equity and its Total Current Liabilities accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lasa Supergenerics Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Total Stockholder Equity vs Total Current Liabilities

Total Stockholder Equity vs Total Current Liabilities Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Lasa Supergenerics Total Stockholder Equity account and Total Current Liabilities. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Lasa Supergenerics' Total Stockholder Equity and Total Current Liabilities is -0.22. Overlapping area represents the amount of variation of Total Stockholder Equity that can explain the historical movement of Total Current Liabilities in the same time period over historical financial statements of Lasa Supergenerics Limited, assuming nothing else is changed. The correlation between historical values of Lasa Supergenerics' Total Stockholder Equity and Total Current Liabilities is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Stockholder Equity of Lasa Supergenerics Limited are associated (or correlated) with its Total Current Liabilities. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Current Liabilities has no effect on the direction of Total Stockholder Equity i.e., Lasa Supergenerics' Total Stockholder Equity and Total Current Liabilities go up and down completely randomly.

Correlation Coefficient

-0.22
Relationship DirectionNegative 
Relationship StrengthInsignificant

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Total Current Liabilities

Total Current Liabilities is an item on Lasa Supergenerics balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Lasa Supergenerics Limited are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.
Most indicators from Lasa Supergenerics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Lasa Supergenerics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lasa Supergenerics Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Tax Provision is likely to gain to about 27.5 M in 2024, whereas Selling General Administrative is likely to drop slightly above 29 M in 2024.
 2021 2022 2023 2024 (projected)
Depreciation And Amortization145.1M134.2M106.7M116.9M
Interest Income403K41.6M37.4M46.9M

Lasa Supergenerics fundamental ratios Correlations

-0.79-0.930.91-0.610.660.790.92-0.81-0.41-0.94-0.45-0.560.42-0.72-0.19-0.160.49-0.90.710.34-0.91-0.90.51-0.57-0.95
-0.790.7-0.80.84-0.22-0.81-0.560.980.60.670.720.81-0.140.97-0.110.47-0.230.87-0.21-0.080.610.81-0.040.220.79
-0.930.7-0.860.54-0.83-0.82-0.950.690.330.990.370.44-0.420.620.190.04-0.470.93-0.81-0.270.990.92-0.720.690.97
0.91-0.8-0.86-0.460.480.730.84-0.84-0.58-0.85-0.65-0.410.13-0.68-0.03-0.10.25-0.920.690.14-0.85-0.810.44-0.65-0.84
-0.610.840.54-0.46-0.22-0.76-0.380.770.40.550.290.97-0.40.87-0.150.62-0.420.620.01-0.220.410.750.05-0.040.72
0.66-0.22-0.830.48-0.220.560.84-0.20.02-0.840.1-0.110.54-0.17-0.350.190.53-0.60.860.35-0.86-0.680.94-0.68-0.74
0.79-0.81-0.820.73-0.760.560.75-0.8-0.39-0.8-0.45-0.70.33-0.810.3-0.570.4-0.830.480.27-0.74-0.840.38-0.58-0.86
0.92-0.56-0.950.84-0.380.840.75-0.58-0.25-0.96-0.31-0.320.36-0.47-0.230.010.41-0.840.90.26-0.97-0.80.76-0.77-0.9
-0.810.980.69-0.840.77-0.2-0.8-0.580.670.660.770.76-0.10.95-0.130.5-0.220.86-0.26-0.120.620.78-0.050.280.77
-0.410.60.33-0.580.40.02-0.39-0.250.670.30.560.460.260.49-0.180.340.130.54-0.150.060.310.41-0.020.190.4
-0.940.670.99-0.850.55-0.84-0.8-0.960.660.30.280.45-0.490.590.20.03-0.540.89-0.82-0.330.980.93-0.720.680.97
-0.450.720.37-0.650.290.1-0.45-0.310.770.560.280.30.420.68-0.120.260.290.65-0.110.270.360.330.110.220.34
-0.560.810.44-0.410.97-0.11-0.7-0.320.760.460.450.3-0.290.83-0.160.7-0.320.540.09-0.170.310.640.16-0.120.64
0.42-0.14-0.420.13-0.40.540.330.36-0.10.26-0.490.42-0.29-0.23-0.07-0.110.98-0.160.30.86-0.37-0.550.37-0.18-0.47
-0.720.970.62-0.680.87-0.17-0.81-0.470.950.490.590.680.83-0.23-0.180.6-0.320.78-0.1-0.20.520.760.040.140.73
-0.19-0.110.19-0.03-0.15-0.350.3-0.23-0.13-0.180.2-0.12-0.16-0.07-0.18-0.69-0.010.1-0.280.160.260.05-0.33-0.190.15
-0.160.470.04-0.10.620.19-0.570.010.50.340.030.260.7-0.110.6-0.69-0.180.150.3-0.3-0.070.210.38-0.020.18
0.49-0.23-0.470.25-0.420.530.40.41-0.220.13-0.540.29-0.320.98-0.32-0.01-0.18-0.250.340.92-0.43-0.610.37-0.26-0.52
-0.90.870.93-0.920.62-0.6-0.83-0.840.860.540.890.650.54-0.160.780.10.15-0.25-0.63-0.060.90.89-0.50.570.92
0.71-0.21-0.810.690.010.860.480.9-0.26-0.15-0.82-0.110.090.3-0.1-0.280.30.34-0.630.27-0.88-0.590.91-0.88-0.68
0.34-0.08-0.270.14-0.220.350.270.26-0.120.06-0.330.27-0.170.86-0.20.16-0.30.92-0.060.27-0.25-0.390.26-0.29-0.3
-0.910.610.99-0.850.41-0.86-0.74-0.970.620.310.980.360.31-0.370.520.26-0.07-0.430.9-0.88-0.250.86-0.80.740.92
-0.90.810.92-0.810.75-0.68-0.84-0.80.780.410.930.330.64-0.550.760.050.21-0.610.89-0.59-0.390.86-0.520.50.97
0.51-0.04-0.720.440.050.940.380.76-0.05-0.02-0.720.110.160.370.04-0.330.380.37-0.50.910.26-0.8-0.52-0.76-0.58
-0.570.220.69-0.65-0.04-0.68-0.58-0.770.280.190.680.22-0.12-0.180.14-0.19-0.02-0.260.57-0.88-0.290.740.5-0.760.54
-0.950.790.97-0.840.72-0.74-0.86-0.90.770.40.970.340.64-0.470.730.150.18-0.520.92-0.68-0.30.920.97-0.580.54
Click cells to compare fundamentals

Lasa Supergenerics Account Relationship Matchups

Lasa Supergenerics fundamental ratios Accounts

201920202021202220232024 (projected)
Common Stock Shares Outstanding22.7M22.9M40.7M50.1M57.6M39.2M
Total Assets2.3B2.1B2.0B1.6B1.5B1.7B
Short Long Term Debt Total484.9M194.6M201.7M217.7M220.8M209.7M
Other Current Liab60.8M63.4M76.7M114.2M127.4M79.0M
Total Current Liabilities759.2M405.4M435.7M427.3M488.7M531.6M
Total Stockholder Equity1.4B1.6B1.5B1.2B966.8M1.3B
Other Liab3.6M4.6M84.1M70.0M80.5M84.6M
Net Tangible Assets990.2M1.4B1.5B1.4B1.7B1.3B
Property Plant And Equipment Net1.5B1.4B1.2B927.8M863.3M1.1B
Current Deferred Revenue75.8M77.2M73.3M(217.7M)226K214.7K
Net Debt459.3M156.2M91.3M209.7M214.7M428.2M
Retained Earnings32.8M207.3M144.1M(253.7M)(469.8M)(446.3M)
Accounts Payable337.3M127.2M169.1M94.3M140.5M219.8M
Cash25.7M38.4M110.4M8.0M6.1M5.8M
Non Current Assets Total1.6B1.4B1.3B1.2B1.1B1.2B
Non Currrent Assets Other(1.5B)5.9M(5K)1K7.1M7.5M
Other Assets39.3M5.9M(1K)1K900.0855.0
Cash And Short Term Investments25.7M38.4M171.9M23.9M15.0M14.2M
Net Receivables206.5M147.7M185.6M24.8M36.4M34.6M
Liabilities And Stockholders Equity2.3B2.1B2.0B1.6B1.5B1.7B
Non Current Liabilities Total146.0M84.1M70.0M28.4M53.2M50.6M
Inventory263.0M172.6M115.0M139.0M190.4M195.3M
Other Current Assets263.5M279.0M251.8M229.3M137.7M242.3M
Total Liab905.2M489.4M505.7M455.7M541.9M764.1M
Short Long Term Debt343.5M194.6M201.7M217.7M220.8M244.4M
Total Current Assets758.7M643.2M719.3M392.2M378.9M564.0M
Accumulated Other Comprehensive Income(501.7M)(673.5M)555.4M515.8M593.1M622.8M
Cash And Equivalents34.9M5.6M61.5M15.9M18.3M21.8M
Short Term Debt324.3M174.5M201.7M217.7M220.8M214.8M
Intangible Assets62.3M54.5M44.7M185.3M142.6M93.0M
Property Plant Equipment1.5B1.4B1.2B927.8M835.0M1.1B
Net Invested Capital1.9B1.6B1.5B1.2B1.2B1.3B
Net Working Capital(454K)237.9M283.6M(35.1M)(109.8M)(104.3M)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Lasa Stock Analysis

When running Lasa Supergenerics' price analysis, check to measure Lasa Supergenerics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lasa Supergenerics is operating at the current time. Most of Lasa Supergenerics' value examination focuses on studying past and present price action to predict the probability of Lasa Supergenerics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lasa Supergenerics' price. Additionally, you may evaluate how the addition of Lasa Supergenerics to your portfolios can decrease your overall portfolio volatility.